{
  "catalogId": "ec85e404-c745-4f51-8519-0383ce9e29cb",
  "name": "BICALUTAMIDE TEVA ® 150 MG",
  "status": "draft",
  "category": "prescription",
  "registrationValidity": "valid",
  "registrationNumber": "140 83 31741 00",
  "treatmentDescriptions": "In patients with locally advanced prostate cancer (T3-T4  any N  M0  T1-T2  N+  M0)  Bicalutamide is indicated as immediate therapy either alone or as adjuvant to treatment by radical prostatectomy or radiotherapy. The management of patients with locally advanced  non-metastatic prostate cancer for whom surgical castration or other medical intervention is not considered appropriate or acceptable.",
  "termsOfIssue": "Prescription required",
  "form": "tablets",
  "route": "per os",
  "site": "",
  "method": "",
  "administrationNotes": "",
  "ingredients": "BICALUTAMIDE",
  "codes": {
    "atc5": {
      "system": "WHO ATC Classification",
      "code": "L02BB03",
      "name": "BICALUTAMIDE"
    }
  },
  "contraindications": "",
  "sideEffect": "",
  "warnings": "תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת",
  "alternativeMedications": [],
  "packaging": [
    {
      "name": "BICALUTAMIDE TEVA 150MG 30TAB",
      "manufacturer": {
        "name": "טבע",
        "countryOfOrigin": "IL"
      },
      "strength": {
        "value": 0,
        "unit": ""
      },
      "quantity": {
        "value": 30.0,
        "unit": "units"
      },
      "packagingDescription": "BLISTER PVDC/ALUMINIUM",
      "shelfLife": "36",
      "storageConditions": "",
      "codes": {
        "moh": "6271",
        "yarpa": "80700",
        "pharmasoft": "2488"
      },
      "manufacturersAdministrationRecommendation": "",
      "pricing": {
        "currency": "ILS",
        "maxWholesalePrice": 361.4738,
        "retailMargin": 17.5,
        "maxRetailPrice": 424.731715,
        "maxPriceWithVAT": 501.1834237
      }
    }
  ],
  "metadata": {
    "version": "1.4",
    "lastUpdated": "2025-08-01T12:18:44.340815"
  }
}